[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 524
Citations 0
Capitol Health Call
November 13, 2013

Researchers Promote Science to Curb Methamphetamine Addiction

JAMA. 2013;310(18):1912. doi:10.1001/jama.2013.281413

Members of the House Subcommittee on Research and Technology heard testimony September 18 regarding how science may help combat methamphetamine (meth) addiction.

More than 14 million individuals worldwide are believed to be using amphetamine-type stimulants for nonmedical purposes. In the United States, in 2010, almost 6% of admissions to publicly funded drug treatment programs were for amphetamine-related problems.

Edythe D. London, PhD, professor of addiction studies at the David Geffen School of Medicine, University of California, Los Angeles, testified before the subcommittee that more than 2 decades of concerted efforts have failed to produce broadly effective pharmaceutical medications for meth dependence and that behavioral treatments, while effective, have high dropout rates.